Summary
For Year 2026-27, Sun Pharmaceutical Industries reports the following shareholding: Total Promoters at 54.48%, Mutual Fund at 11.96%, Insurance at 6.83%, Foreign Institutional Investors at 15.93%, Domestic Institutional Investors at 2.31%, and Retail at 8.48%. This breakdown provides a quick snapshot of ownership distribution for Sun Pharmaceutical Industries in 2026-27.
Sun Pharmaceutical Industries FAQs
As of 04-2026, the promoter shareholding in Sun Pharmaceutical Industries stands at 54.48% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Sun Pharmaceutical Industries is 15.93% and 2.31% respectively.
The retail shareholding of the Sun Pharmaceutical Industries is 8.48%.
Changes in shareholding patterns of Sun Pharmaceutical Industries can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Sun Pharmaceutical Industries are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Sun Pharmaceutical Industries Associated Pages
- Sun Pharmaceutical Industries Share Price
- Sun Pharmaceutical Industries Share Price chart
- Sun Pharmaceutical Industries Fundamental Analysis
- Sun Pharmaceutical Industries Technical Analysis
- Sun Pharmaceutical Industries Peer Comparison
- Sun Pharmaceutical Industries Share Price History
- Sun Pharmaceutical Industries Dividend
- Sun Pharmaceutical Industries Board of Directors
